Related by context. All words. (Click for frequent words.) 67 APR Labtec 66 Receives Approvable Letter 65 Announces Tentative Approval 65 Files IND 65 Submits NDA 65 OTCBB NVDL 64 Receives Orphan Drug Designation 64 AMEX NVD 64 Initiates Phase II 63 Begins Dosing 63 Release Capsules 63 Completes Patient Enrollment 63 Presents Preclinical Data 62 Receives Tentative Approval 62 FDA Accepts 62 NASDAQ DRRX 62 topical gel formulation 62 developing Zerenex ferric 62 Licenses Novel 62 Investigational Oral 62 Initiates Phase III 62 Initiates Enrollment 61 Launches Generic Version 61 Initiates Clinical Trial 61 Presents Positive 61 Intravenous Human 61 Atripla combines 61 Announce License Agreement 61 DRRX 61 Orally administered 61 Completes Enrollment 60 NYSE AMEX NVD 60 PRN FDA Approves 60 Phase IIb Trial 60 TO AVOID PREGNANCY WHILE 60 Nasdaq EPCT 60 Mylan Receives Approval 60 Files Investigational 60 Receives Orphan Drug 60 Therapeutic Competitors Companies 60 Initiates Dosing 60 Initiates Phase 2b 60 Enrolls First 60 Submits Supplemental 60 Submits Investigational 60 non nucleoside inhibitor 60 submitted Biologics License 60 AMEX KAL 60 Therapeutic Competitors companiesandmarkets.com adEgemonye 60 5 HT3 antagonist 59 SPRYCEL ® 59 Submits Biologics License Application 59 Initiates Clinical 59 Oral Suspension USP 59 Submits Response 59 WeissComm Partners +#-#-#-# 59 Submits IND 59 Nasdaq IPXL 59 Nasdaq PGNX 59 Nasdaq XTLB 59 Commences Phase 59 Nasdaq OSIP 59 Receives Positive Opinion 59 SpeBio joint venture 59 Receives Milestone Payment 59 Announces Initiation 59 AMEX NVD specialty 59 Initiates Phase 59 Drug Candidate 59 Nasdaq ANPI 59 Gets FDA Clearance 59 brand ciclesonide HFA 59 FDA Clears 59 NASDAQ AVNR 59 miconazole Lauriad 59 Meets Primary Endpoint 59 Announces Poster Presentations 59 OTCBB GNTA 58 NicVAX TM 58 PEGylated Fab fragment 58 NASDAQ SHPGY 58 Receives Complete Response 58 Initiates Clinical Trials 58 OTCBB OHRP 58 Inc. Nasdaq OXGN 58 Mg Uk 58 NASDAQ CRTX 58 novel emulsion formulation 58 Granted Orphan Drug 58 Announce Licensing Agreement 58 COLAZAL R 58 Tezampanel 58 Nasdaq SHPGY 58 markets COLAZAL 58 Nasdaq DEPO 58 Initiate Clinical Trial 58 Gonal f R 58 Mg Usa 58 selective estrogen receptor modulator 58 OTCBB AFLB 58 Novel Oral 58 Obtains FDA 58 Nasdaq MOGN 58 Nasdaq REGN 58 Exherin 58 Vitrasert R 57 Reacquires 57 FOLOTYN ® 57 proprietary polysaccharide 57 Xyfid TM 57 Nasdaq MYL 57 Nasdaq CTIC 57 Present Preclinical Data 57 Nasdaq PARD 57 PEGylated anti 57 vinorelbine tartrate 57 Kuvan R 57 Presents Preclinical 57 Inc. OTCBB VYTR 57 Nasdaq TARG 57 Presents Positive Preclinical 57 Cypress Bioscience Inc 57 Albuferon TM 57 Nasdaq MRNA 57 Nasdaq HALO 57 markets XIFAXAN ® 57 dasatinib Sprycel ® 57 markets HP Acthar 57 AMEX NVD visit 57 OTCBB CVBT 57 Inc. Nasdaq SEPR 57 BIOTECHNOLOGY SOURCE 57 Receive Milestone Payment 57 Initiate Phase 57 Vaccine Recombinant 57 Kinase Inhibitor 57 TRANSDUR ™ 57 NDA Submission 57 Nasdaq SLXP 57 FDA APPROVES 57 initiated Phase Ib 57 Civacir TM Hepatitis C 57 developing Bicifadine serotonin 57 Investigational Compound 57 small molecule Hedgehog 57 Reports Preclinical Data 57 Inc. NASDAQ AVII 57 Aradigm Corporation 57 liposomal formulation 57 Nasdaq TSPT 57 NOVN 56 Announce Collaboration Agreement 56 Taro Receives 56 QLTI 56 Apricus Biosciences 56 Pegloticase 56 R roscovitine CDK cyclin 56 Phase 2b Clinical Trial 56 PSDV 56 Risperidone Oral Solution 56 NASDAQ DDSS 56 Nasdaq IDIX 56 Study Evaluating 56 selective A2A adenosine receptor 56 Inc. Nasdaq IMGN 56 Announces Immediate Availability 56 Pivotal Phase III 56 Nasdaq VNDA 56 include Phenoptin TM 56 Reveals Positive 56 virus HCV protease inhibitor 56 NASDAQ CGPI 56 Vaccine Adjuvant 56 Horizant ™ 56 candidate AQ4N 56 JAK2 Inhibitor 56 Nasdaq AVNC 56 NASDAQ IDEV 56 combines bupropion 56 2A receptor agonist 56 THERAPEUTICS INC 56 Opterone R 56 researches develops licenses 56 Nasdaq ALXA 56 therapeutic peptide Thymosin 56 Fast Track Status 56 NASDAQ CRXL 56 Nasdaq NPSP 56 proprietary intranasal insulin 56 MBRX 56 Combination REOLYSIN R 56 OTCBB TDLP 56 RTP #i 56 BioSante Pharmaceuticals Announces 56 Achieves Primary Endpoint 56 pralatrexate injection folate analogue 56 Nasdaq PHRM 56 GVAX ® 56 Nasdaq DVAX 56 CIMZIA r 56 oral prodrug 55 memantine HCl 55 PNP inhibitor 55 NASDAQ EMIS 55 Milestone Payments 55 Vitamin D analogue 55 Commence Phase 55 ABLYNX 55 Nasdaq SPPI 55 Nasdaq BPAX 55 hyaluronidase enzyme 55 OTCBB ADXS 55 candidate deforolimus 55 LSE SHP.L 55 Therapeutic Competitors 55 GlaxoSmithKline Biologicals SA 55 VentiRx Pharmaceuticals 55 Receives Fast Track 55 BTRX 55 TRACON Pharmaceuticals 55 Nasdaq ONXX 55 TSX VENTURE IGX OTCBB 55 Inc. OTCBB LEVP 55 NYSE MRX 55 Barrier Therapeutics Inc. 55 PHRM 55 NASDAQ OMER 55 humanized monoclonal 55 Luveris R Ovidrel R 55 Crofelemer budesonide foam 55 OctoPlus licensed 55 Hsp# Inhibitor 55 Personalized Immunotherapy 55 Javelin Pharma 55 PDE4 inhibitor 55 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 55 AMEX RGN 55 NASDAQ TARG 55 Nasdaq ACAD 55 Earns Milestone Payment 55 NASDAQ BJGP 55 Polymerase Inhibitor 55 Nasdaq CLDX 55 novel histone deacetylase 55 NASDAQ RNAI 55 TSPT 55 Nasdaq NBIX 55 selective phosphodiesterase 55 TKPHF 55 Nasdaq IDEV 55 Pharmacokinetics PK 55 Roche OTC RHHBY 55 IG HCR ;) CO 55 androgen receptor antagonist 55 Onyx Pharmaceuticals Inc 55 nasal calcitonin product 55 OTCBB FCSC 55 AzaSite ISV 55 Nasdaq ALTH 55 novel MetAP 2 55 AAG geldanamycin analog 55 Nicotine Conjugate Vaccine 55 CTRX 55 AMEX DDD 55 NASDAQ OSCI 55 Nasdaq ICOS 55 NASDAQ SCLN 55 Alnylam Pharmaceuticals Inc 55 Jumps Higher 55 5 lipoxygenase inhibitor 54 peptidic compound 54 Shrink OTCBB INKN 54 Nasdaq ADLR 54 VCRT 54 proprietary intravenous formulation 54 TapImmune Inc. 54 OTCBB AMAR 54 R sorafenib tablets 54 Ecallantide 54 telomerase therapeutic 54 Alexza Pharmaceuticals Inc 54 ANIK 54 Nasdaq AMAG 54 Transdel Pharmaceuticals Inc. 54 Successfully Completes Phase 54 triciribine phosphate monohydrate 54 CybeRelease Decliners 54 Transcept Pharmaceuticals 54 KRYSTEXXA TM pegloticase 54 Nasdaq KERX 54 Nasdaq BMRN 54 Recombinant Human 54 Awarded Qualifying Therapeutic 54 Inc Therapeutic Competitors 54 R Saizen R 54 hypoxia activated prodrug 54 sitaxsentan sodium 54 NGSX 54 TELINTRA R 54 OTCBB EMIS 54 PHARM 54 Inc. Amex PRW 54 OTCBB DORB 54 Xcytrin R 54 UGNE 54 novel orally inhaled 54 please visit http:/www.vandapharma.com 54 Romidepsin 54 Inc. Nasdaq TRMS 54 AVXL 54 Inc. NASDAQ BPAX 54 Nasdaq ZGEN 54 Staphylococcus aureus Immune Globulin 54 Adenosine A2A 54 Nasdaq LGND 54 oral nucleoside analogue 54 Pruvel TM 54 Inc. Nasdaq AGIX 54 NASDAQ VPHM 54 Advancis Pharmaceutical Corporation 54 dependent kinase inhibitor 54 PDX pralatrexate 54 Expanded Indication 54 GlaxoSmithKline plc GSK 54 NASDAQ XTLB 54 Norgine BV 54 CRTX 54 GILEAD SCIENCES 54 small molecule chemotherapeutic 54 NASDAQ INSM 54 TM Aganocide 54 Trial Evaluating 54 Screenshot Tour 54 sunitinib Sutent ® 54 Solorel ® 54 Euronext Paris Code Isin 54 Nasdaq SOMX 54 BAYRY 54 Cardium Therapeutics TM 54 Nasdaq ENZN 54 phase III isavuconazole 54 die Dateigröße beträgt #,# 54 HCV RNA polymerase 54 Pharma Merck Serono 54 Obtains Exclusive License 54 OGXI 54 sapropterin dihydrochloride Phase 54 Pancreas Cancer Vaccine 54 www.palatin.com 54 NASDAQ MYRX 54 anti CD3 monoclonal 54 OTCBB IMUC 54 Femring ® 53 Corp. PHRM 53 targeted antifolate 53 TSX CTI 53 Crucell NV NYSE Euronext 53 Nasdaq CYCC 53 OTCBB ARDM 53 humanized interleukin 6 53 IMPACS R 53 TSRX 53 NYSE Amex YMI 53 Teva Pharmaceuticals NASDAQ TEVA 53 Cynapsus Therapeutics Inc. 53 Nasdaq PANC 53 selective kinase inhibitor 53 OTCBB GETA 53 Alnylam Nasdaq ALNY 53 Alnylam ALNY 53 OPTR 53 Vascular Disrupting Agent 53 Indevus Pharma 53 Ohr Pharmaceutical Inc. 53 HuCAL GOLD R 53 JZP 53 Inc. Nasdaq MAXY 53 novel synthetic PEGylated 53 OMRIX Biopharmaceuticals Inc. 53 Receives NASDAQ 53 Inc SPPI 53 TSX NVN 53 Migraine Drug 53 NASDAQ LGND 53 Penwest Pharma 53 Syntonix Pharmaceuticals 53 NYSE MYL 53 ALIM 53 non porcine pancreatic 53 TRBN 53 NYSE Amex PBTH 53 testosterone buccal system 53 Telik logo TELINTRA 53 Omacetaxine 53 NASDAQ ADLR 53 hypereosinophilic syndrome 53 NYMX 53 orally inhaled migraine 53 Kelly Luethje #-#-# 53 Alfacell proprietary ribonuclease 53 essential thrombocythemia ET 53 ONCY 53 Nasdaq AVII 53 Nasdaq SNSS 53 Aptamer 53 ChemGenex Pharmaceuticals Limited 53 LymphoStat B belimumab 53 Inc FRX 53 Phase 2a Trial 53 Announces Presentation 53 Nasdaq GTCB 53 Antisense Oligonucleotides 53 R MSCRAMM 53 Completes Dosing 53 Inc. Nasdaq SUPG 53 TNF Tumor Necrosis Factor 53 NASDAQ IDRA 53 GTC NASDAQ GTCB 53 Reports Receipt 53 negative allosteric modulator 53 RDYN 53 BPAX 53 Phase 1b Clinical Trial 53 Nasdaq THLD 53 Emergent marketed 53 Inc. Nasdaq INSM 53 candidates Azedra TM 53 TLR9 agonist 53 receptor tyrosine kinase inhibitor 53 NASDAQ WCRX 53 Rhucin ® recombinant 53 Inc. NASDAQ SGEN 53 NASDAQ AVII 53 Receives Notice Related 53 SHP.L 53 DOVP 53 lead molecular radiotherapeutic 53 Report companiesandmarkets.com adds 53 XL# anticancer compounds 53 Nasdaq ACOR 53 Randomized Phase 53 Connetics Corporation 53 Long acting beta2 53 tests miRview TM 53 Systemic Delivery 53 By JAMAAL ABDUL 53 class anticancer quinolone 53 AN# topical anti 53 Nasdaq BDSI 53 Suppository Hydrocortisone Acetate Rectal 53 Fibrocell Science Inc. 53 LEVADEX ™ 53 Inc. NASDAQ MRNA 53 rusalatide acetate 53 LymphoStat B TM 53 AMEX JAV 53 Nasdaq IMMU 53 Patient Enrollment 53 AMEX PTN 53 Inc. Nasdaq AVRX 53 DOV Pharmaceutical Inc. 53 platinum chemotherapeutic 53 Inc. Nasdaq MITI 53 Albugon 52 Nasdaq IMGN 52 LGND 52 Nasdaq IDRA 52 Abraxis Bioscience Inc. 52 candidates Azedra 52 molecular therapeutics immunotherapies 52 #HT# 52 developing ACAPODENE 52 Drug Fails 52 POSIDUR TM ELADUR TM 52 Amex ANX 52 Nasdaq RPRX 52 Inc. NASDAQ SUPG 52 investigational humanized monoclonal antibody 52 neuronal nicotinic receptor NNR 52 Targanta Therapeutics Corporation 52 ASE SVA 52 antibody blinatumomab MT#/MEDI-# 52 IPXL 52 lintuzumab SGN 52 NASDAQ CLDX 52 Nasdaq GENR 52 CRXL 52 NSTK 52 NASDAQ GTCB 52 OTCStockExchange.com Stock Alert 52 Nasdaq ABII 52 ATRA IV 52 CLINICAL DATA 52 Nasdaq CADX 52 Nasdaq AVNR 52 NASDAQ PCYC 52 adenosine A2A 52 AUXL 52 Genentech sanofi aventis 52 mertansine 52 #.#.# Released 52 Inc. Nasdaq NEOL 52 NASDAQ QCOR 52 NVGN 52 NASDAQ ACOR 52 Nasdaq SCLN 52 Sinks Lower 52 LibiGel ® 52 otcstockexchange.com 52 systemic lupus erythematosus rheumatoid 52 NASDAQ KERX 52 Namenda Memantine HCl 52 humanized anti 52 mediate RNAi 52 candidate XP# 52 Announce Merger Agreement 52 Milestone Payment 52 newratings.com Analyst Jonathan Aschoff 52 Inc. OTCBB ECTE 52 CyDex Pharmaceuticals Inc. 52 NASDAQ PGNX 52 Inc. NASDAQ MEDX 52 Nasdaq VVUS 52 XOMA 3AB biodefense 52 LibiGel transdermal testosterone gel 52 Tapestry Pharmaceuticals Inc. 52 CYCLOSET ® 52 NASDAQ ONXX 52 ViroPharma NASDAQ VPHM 52 METOZOLV ™ ODT metoclopramide 52 DiLA2 52 NASDAQ TSPT 52 BFRM 52 Patient Enrolment 52 SCRX 52 Salix Pharmaceuticals Ltd 52 include Altastaph TM 52 Fovea Pharmaceuticals SA 52 OTC PVCT 52 MKC# MT 52 SinuNase TM 52 Catalyst Biosciences 52 agonistic human 52 AMEX ANX 52 APCVZ 52 Orphan Status 52 ISPH 52 demonstrated antitumor activity 52 Patent Covering 52 Nasdaq MITI 52 ViroPharma VPHM 52 ISTA Pharmaceuticals 52 Nasdaq SGEN 52 Corp. NASDAQ CYTR 52 Ltd Therapeutic Competitors 52 TKB# 52 SinuNase ™ 52 RegeneRx Biopharmaceuticals Inc. 52 investigational pan BCR 52 nanofiltered plasma derived 52 GILD GILD 52 DepoMed 52 PGL# 52 dasatinib Sprycel 52 OTC BB EMIS 52 Nasdaq PPHM clinical 52 Cellgate Inc. 52 topical anti infective 52 NASDAQ BDSI 52 Nasdaq WCRX 52 orally administered inhibitor 52 GSK.L 52 Humanized Anti 52 Investorideas.com newswire BioSante PharmaceuticalLarne Holyhead 52 ReSharper version #.# 51 KOSN 51 Nasdaq SVNT 51 Tibotec BVBA 51 compan productivity add 51 agonist LABA 51 peptide conjugated 51 Nasdaq DYAX 51 Vion Pharmaceuticals 51 Release Date Announced 51 HuMax 51 ENCY 51 use transdermal sumatriptan 51 Nasdaq BCRX 51 NASDAQ ALXN 51 BIIB BIIB 51 Protalix Biotherapeutics Inc. 51 GVAX R 51 Genelabs Technologies Inc. 51 humanized therapeutic 51 Momenta Pharmaceuticals MNTA 51 telomerase inhibitor drug 51 imatinib Gleevec ® 51 plc LSE SHP 51 OTC BB PVCT 51 Nasdaq MYRX 51 Progenics Pharmaceuticals Inc 51 IMiDs ® 51 visit http:/www.mannkindcorp.com 51 CysDisplay R 51 small molecule thrombopoietin 51 MEMY 51 NASDAQ BMRN 51 BiTE R 51 oral Hsp# inhibitor 51 Nasdaq APPY 51 Veronate R 51 Nasdaq VRTX 51 NASDAQ VVUS 51 OPXA 51 Exploit collaboration 51 Optimer Pharmaceuticals Inc 51 Nasdaq FURX 51 Files Shelf Registration Statement 51 Oral Fingolimod 51 compound perifosine 51 http:/www.palatin.com 51 NASDAQ OPTR 51 Inc. OTCBB APNS 51 commercializing anti infective 51 Novelos Therapeutics Inc. 51 TÎ ² 4 51 Pralatrexate 51 NASDAQ REGN 51 PTIE 51 NASDAQ CBST today 51 Factor VIIa 51 NASDAQ ENMD 51 DVAX 51 Kythera Biopharmaceuticals 51 NASDAQ MOGN 51 derivatives Radilex TM 51 Pivotal Phase 51 approved incretin mimetic 51 Immunogen IMGN 51 NASDAQ ALTH 51 Rindopepimut 51 OTCBB NPHC 51 OTCBB PVCT 51 oral immunomodulatory 51 Inc. NASDAQ BDSI 51 Prostate Cancer Vaccine 51 inhibit oxidative stress 51 selective modulator 51 Completes Patient Enrolment 51 NASDAQ ISIS 51 platform HDL Mimetic 51 HEPH 51 AKT inhibitor 51 oral proteasome inhibitor 51 ARYX 51 commercialize becocalcidiol patented 51 Incyte Corp 51 Aganocide ® 51 antiangiogenesis therapies 51 small molecule glucokinase 51 NASDAQ IDIX 51 OncoGenex Pharmaceuticals Inc. 51 Nasdaq ALSE 51 BENLYSTA ® 51 NASDAQ MNTA 51 NASDAQ ACAD 51 NasdaqGM ADLR today 51 oral dihydropyrimidine dehydrogenase DPD 51 faropenem medoxomil 51 JadeLiquid Software announced 51 Collegium Pharmaceutical Inc. 51 Treatment Naïve 51 CompanionLink Announces 51 Cyclacel Pharmaceuticals Inc. 51 signal transduction inhibitor 51 OTCBB NNVC 51 Nasdaq HALO biopharmaceutical 51 Nasdaq CRXL 51 systemic juvenile idiopathic 51 4SC AG ISIN DE# 51 CancerVax Corporation 51 Eurand NV 51 Flamel Technologies 51 Phase IIb Clinical Trial 51 product candidate Lpathomab 51 Corp. AMEX CVM 51 plc AMRN 51 Nasdaq MBRX 51 PI3K inhibitor 51 Skymark Research Initiates Independent 51 Cutanea Life Sciences 51 Nasdaq LXRX 51 Alligator Bioscience AB 51 treat refractory angina 51 OTCBB NRGX 51 Nasdaq CRME 51 NYSE Amex AEN 51 MAb therapy 51 ABL inhibitor 51 cortisol synthesis 51 Nasdaq MITI biopharmaceutical 51 NASDAQ EPIX 51 CYP#A# CYP#D# 51 Corp. ADLR 51 please visit www.dyax.com 51 EPCT 51 NASDAQ ANPI 51 Inc. OTCBB BCLI 51 PDE4 51 NASDAQ ACHN 51 nilotinib Tasigna ® 51 antisense inhibitors 51 AMEX PLX 51 Inc. NASDAQ OXGN 51 NASDAQ ENZN 51 Frankfurt XMP 51 SMMX 51 OTCBB NVLT 50 Inc NGSX 50 NASDAQ ARRY 50 Cubist Pharmaceuticals Inc 50 P#X# antagonist 50 Plc Ads SHPGY 50 NASDAQ INGN 50 Aganocide 50 Nasdaq MNKD focuses 50 TRIOLEX HE# APOPTONE HE# 50 Inc. Nasdaq CYCC 50 Gendux AB 50 Adventrx Pharmaceuticals 50 NS5b 50 adecatumumab MT# 50 SAR# [002] 50 Enhanze TM Technology 50 Nasdaq AUXL 50 Inc. Nasdaq VIAP 50 inflammatory PDE 50 Initiated Phase 50 hypoxia selective 50 Inc. Nasdaq CRTX 50 OncoGenex Pharmaceuticals 50 NOVN.VX 50 Maxy G# 50 NASDAQ CPEX 50 SNMX 50 OTCBB ILNS 50 NASDAQ BIOD 50 cytidine nucleoside analog 50 NEXM 50 Nasdaq TRBN 50 Locked Nucleic Acid 50 CardioVascular BioTherapeutics Inc. 50 Tesetaxel 50 ARXT 50 EPIX Pharmaceuticals Inc. 50 Collaborators Publish 50 ROSG 50 ENL recurrence 50 Pruvel ™ 50 markets Testim ® 50 2 Microglobulin beta 50 Akorn Inc 50 TSX VENTURE MOM 50 NYSE Amex RPC 50 Warner Chilcott plc 50 NASDAQ PPHM clinical 50 Collaborators Present 50 OTCBB CGXP 50 Inhibits 50 NYSE Amex PTN 50 PI3K/Akt pathway inhibitor 50 CELGENE 50 Nasdaq CYTX 50 Generex Biotechnology Corp. 50 HUMAN GENOME SCIENCES 50 Nasdaq ACHN 50 www.ucb.com 50 introduced NEUGENE 50 NASDAQ VNDA 50 MNTA 50 huC# DM4 50 Anika Therapeutics 50 NASDAQ IMGN 50 M# rationally 50 fibrosis IPF 50 candidate REP# 50 Aurora Kinase 50 ADAGEN 50 Ipsen SA 50 ONTY 50 ZIOP 50 bèta 50 pipeline ImmunoGen collaborators 50 PXSL 50 PVCT 50 QuantRx Biomedical Corporation 50 NASDAQ NPSP 50 cyclin dependent kinase inhibitor 50 PWRM.OB 50 Vicuron Pharmaceuticals 50 dual PPAR peroxisome 50 Epothilone D 50 antibiotic candidate Ramoplanin 50 Imatinib mesylate 50 Aegerion Pharmaceuticals Inc. 50 Nastech Pharmaceutical Company 50 MTP inhibitor 50 OTCBB PYTO 50 Nasdaq VRTX today 50 AKRX 50 R rilonacept Injection 50 oncolytic virus therapies 50 ANGN 50 adrenergic agonist 50 Neutrolin 50 TSX COS.UN TSX 50 Graceway Pharmaceuticals LLC 50 Nasdaq ANDS 50 NASDAQ AEZS 50 Indevus Pharmaceuticals 50 Tech DVAX 50 Inc. Nasdaq VVUS 50 ARCA biopharma Inc. 50 Isis Pharma 50 Ximian Desktop 50 Regeneron Pharma 50 beta3 50 DNA methyltransferase inhibitors 50 MBRK 50 Inc. NASDAQ SIRT 50 Factor Receptor 50 LAB CGRP 50 Seattle Genetics SGEN 50 NASDAQ ZIOP 50 biocompatibility capabilities 50 ACHN 50 including cyclosporine methotrexate 50 OTCBB CTIX 50 Javelin Pharmaceuticals Inc 50 Multiple Vulnerabilities 50 CYT# potent vascular disrupting 50 Takeda Kyowa Hakko Kirin 50 BNVI 50 Inc. NASDAQ AGIX 50 IMRX 50 Nasdaq MNKD focused 50 NASDAQ HALO 50 RGDX 49 Nasdaq OPTR 49 Adenosine Therapeutics 49 Pharmos Corporation 49 www.ucb group.com 49 NASDAQ NRGN 49 Ltd. OTCBB IMUC 49 Ception Therapeutics 49 NASDAQ IMMU 49 NASDAQ ISPH 49 Inc FRX FRX 49 mGluR5 negative 49 Xcyte Therapies Inc. 49 targeting CD# 49 IDIX 49 NASDAQ PANC 49 dipeptidyl peptidase IV 49 Nasdaq CBST 49 KV.A 49 somatostatin analogue 49 NASDAQ ALNY 49 ZGNX 49 Nasdaq CYCC Nasdaq CYCCP 49 VTUS 49 non nucleoside HCV 49 OTCBB CAEH 49 Privus Mobile iPhone 49 DORB 49 GENR 49 oral ghrelin agonist 49 NASDAQ SOMX specialty 49 HCV NS5B polymerase 49 IMPAX Laboratories Inc. 49 monoclonal antibody IgG1 Mab 49 please visit http:/www.supergen.com 49 MSCRAMM ® 49 ADVENTRX Pharmaceuticals Inc. 49 please visit http:/www.atherogenics.com 49 NASDAQ ROSG leading 49 NASDAQ AVEO 49 AtuRNAi 49 MOGN 49 By Tim Conneally 49 NASDAQ GNTA 49 Enzon Pharmaceuticals Inc 49 PROLOR Biotech Inc. 49 Nasdaq HGSI 49 Xoma Ltd 49 CYP#A# substrate 49 Endo Pharmaceuticals Nasdaq ENDP 49 OTCBB QTXB 49 Inc. NASDAQ ACOR 49 ONYX Pharmaceuticals 49 5 HT2A inverse 49 neuropathic pain metabolic diseases 49 Vernalis plc 49 Inc. NASDAQ IDMI 49 Bruton tyrosine kinase 49 beta1 49 Supernus Pharmaceuticals Inc. 49 Cadence Pharmaceuticals Inc 49 Inovio Pharmaceuticals 49 Cellegy Pharmaceuticals 49 Omigard TM omiganan pentahydrochloride 49 NASDAQ BPAX 49 using VIAdel TM 49 Metabasis Therapeutics 49 malignant infectious 49 NASDAQ MYL 49 Milestone Payment From 49 DYAX 49 OXGN 49 LEVP 49 Inc. NASDAQ ORXE 49 VRUS 49 OTCBB ADMP 49 NASDAQ MNKD focuses 49 Nasdaq CYTR 49 anti botulism antibody 49 Iomai Corporation 49 EYET 49 ENZN 49 Momenta Pharma MNTA 49 CRME 49 Pharmacueticals 49 expanded autologous cellular 49 Idenix Pharmaceuticals Inc 49 Biodel Inc 49 NASDAQ MIPI 49 Aspreva Pharmaceuticals Corporation 49 MKC# 49 PANC 49 gastrin analogue TT 49 Acute Myeloid Leukemia AML 49 PPI omeprazole 49 Vertex Pharmaceuticals Inc 49 Proc Am Soc 49 GNLB 49 BY TREVOR HUGHES 49 attach auristatin 49 CADX 49 GlaxoSmithKline MedImmune 49 Biosante Pharmaceuticals 49 Inc. NASDAQ VSGN 49 JetBrains Releases 49 ECTE 49 candidate AP# 49 NYSE Amex RGN 49 virus AAV 49 novel DACH platinum 49 BioSpecifics Technologies Corp. 49 programs visit http:/www.bionovo.com 49 IMMU 49 NASDAQ CADX 49 Sunesis Pharmaceuticals 49 NNVC 49 R DepoCyt 49 Server v#.#.# Mac OS [002] 49 Vical Incorporated NASDAQ VICL 49 nano particle tumor suppressor 49 NASDAQ LXRX 49 Prodarsan R 49 VEGFR2 inhibitor 49 Corp EPCT 49 thrombin component 49 addressing idiopathic pulmonary 49 4.x 5.x 49 Bradmer Pharmaceuticals 49 Nasdaq ALNY 49 ImmunoCellular Therapeutics Ltd. 49 Selective Electrochemical Tumor Ablation 49 Modulates 49 NASDAQ SVNT 49 GlaxoSmithKline plc NYSE 49 Inc. NASDAQ ICGN 49 Davunetide 49 v#.# Released [002] 49 Nasdaq QCOR 49 Array Biopharma Inc 49 accumulate preferentially 49 enhanced skin permeation 48 QTXB 48 Inc SNTS 48 NASDAQ PPHM 48 NASDAQ NBIX 48 TTHI 48 Insmed Incorporated NASDAQ INSM 48 Nasdaq ENMD 48 Tumor necrosis factor 48 v#.# Released [001] 48 Nasdaq GNBT 48 Dendritic Nanotechnologies Inc.